IK

Indivar Kiran Wupparllapalli

Active Director Director DIN 06714665
DIN 06714665 First appointment Sep 2014 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Sep 2014
Shareholding value •••• Premium profile

About Indivar Kiran Wupparllapalli

Data last updated:

Indivar Kiran Wupparllapalli has 12 years in corporate governance. Holds Director role. Currently with 3 companies, including Ongole Institute Of Oncology Private Limited and Shakhambari Healthcare Services Private Limited. Formerly with 5 companies, such as Kurnool Institute Of Oncology Private Limited and Bibi Oncology Services Private Limited. Engaged in General Business, Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹38.43 Cr; the largest is Shakhambari Healthcare Services Private Limited at ₹19.30 Cr (FY 2025).

DIN 06714665
Primary Designation Director
First Appointment 16 Sep 2014
Oldest Company Age 11 yrs
Largest company Shakhambari Healthcare Services Private Limited · ₹19.30 Cr (FY 2025)
Combined revenue ₹38.43 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Aug 20192019₹19.30 Cr (FY 2025)Active
Director20 Aug 20182017₹19.13 Cr (FY 2023)Active
Director08 Jan 20242022–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Sep 20142014₹61.84 Cr (FY 2025)Active
Director09 Sep 20192015₹9.14 Cr (FY 2025)Active
Director21 Nov 20142014₹95.46 Cr (FY 2025)Active
Director07 May 20192019–Strike Off
Director07 May 20152015–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ongole Institute Of Oncology Private Limited
Shakhambari Healthcare Services Private Limited
Sri Hansika Nivriti Fitness Private Limited
Bhadrakali Healthcare Services Private Limited
Premium access

Shareholding and investment profile for Indivar Kiran Wupparllapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indivar Kiran Wupparllapalli

Indivar Kiran Wupparllapalli has 12 years in corporate governance. Holds Director role. Currently with 3 companies, including Ongole Institute Of Oncology Private Limited and Shakhambari Healthcare Services Private Limited. Formerly with 5 companies, such as Kurnool Institute Of Oncology Private Limited and Bibi Oncology Services Private Limited. Engaged in General Business, Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹38.43 Cr; the largest is Shakhambari Healthcare Services Private Limited at ₹19.30 Cr (FY 2025).

Indivar Kiran Wupparllapalli is associated with 3 companies as Director, including Shakhambari Healthcare Services Private Limited (₹19.30 Cr), Kathyayani Medcare Services Private Limited (₹19.13 Cr), Bhadrakali Healthcare Services Private Limited.

Indivar Kiran Wupparllapalli has expertise in General Business, Healthcare.

Indivar Kiran Wupparllapalli has 12 years in corporate governance.

By reported revenue, the largest current company of Indivar Kiran Wupparllapalli is Shakhambari Healthcare Services Private Limited, with revenue of ₹19.30 Cr (FY 2025).

The 2 current companies of Indivar Kiran Wupparllapalli that report revenue have a combined latest revenue of ₹38.43 Cr.

Indivar Kiran Wupparllapalli currently holds positions at 3 companies: Shakhambari Healthcare Services Private Limited (₹19.30 Cr), Kathyayani Medcare Services Private Limited (₹19.13 Cr), Bhadrakali Healthcare Services Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available